| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2019 | Plasma Aldosterone after Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes after Adrenalectomy for Primary Aldosteronism | Wu C.-H.; Yang Y.-W.; Lin Y.-H.; Yang S.-Y.; Lin P.-C.; Chang C.-C.; Tsai Y.-C.; Wang S.-M. | American Journal of Hypertension | 2 | ||
| 2019 | Plasma Aldosterone after Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes after Adrenalectomy for Primary Aldosteronism | Wu C.-H.; VIN-CENT WU ; Yang Y.-W.; Lin Y.-H.; Yang S.-Y.; Lin P.-C.; Chang C.-C.; Tsai Y.-C.; Wang S.-M. | American Journal of Hypertension | 2 | ||
| 2018 | Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease | Teunissen C.E.; MING-JANG CHIU ; Yang C.-C.; Yang S.-Y.; Scheltens P.; Zetterberg H.; Blennow K. | Journal of Alzheimer's disease : JAD | 36 | ||
| 2014 | Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease | Tzen K.-Y.; Yang S.-Y.; TA-FU CHEN ; Cheng T.-W.; Horng H.-E.; Wen H.-P.; Huang Y.-Y.; Shiue C.-Y.; Chiu M.-J. | ACS Chemical Neuroscience | 61 | ||
| 2014 | Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease | Tzen K.-Y.; Yang S.-Y.; Chen T.-F.; Cheng T.-W.; Horng H.-E.; Wen H.-P.; Huang Y.-Y.; Shiue C.-Y.; MING-JANG CHIU | ACS Chemical Neuroscience | 61 | ||
| 2018 | Plasma biomarkers differentiate Parkinson's disease from atypical parkinsonism syndromes | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; Chiu M.-J. | Frontiers in Aging Neuroscience | 10 | ||
| 2018 | Plasma biomarkers differentiate Parkinson's disease from atypical parkinsonism syndromes | Lin C.-H.; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Frontiers in Aging Neuroscience | 10 | ||
| 2017 | Plasma levels of Aβ42 and Tau identified probable Alzheimer's dementia: Findings in two cohorts | Lue L.-F.; Sabbagh M.N.; MING-JANG CHIU ; Jing N.; Snyder N.L.; Schmitz C.; Guerra A.; Belden C.M.; Chen T.-F.; Yang C.-C.; Yang S.-Y.; Walker D.G.; Chen K.; Reiman E.M. | Frontiers in Aging Neuroscience | 33 | ||
| 2017 | Plasma levels of Aβ42 and Tau identified probable Alzheimer's dementia: Findings in two cohorts | Lue L.-F.; Sabbagh M.N.; Chiu M.-J.; Jing N.; Snyder N.L.; Schmitz C.; Guerra A.; Belden C.M.; TA-FU CHEN ; Yang C.-C.; Yang S.-Y.; Walker D.G.; Chen K.; Reiman E.M. | Frontiers in Aging Neuroscience | 33 | ||
| 2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | Chiu M.-J.; YA-FANG CHEN ; Chen T.-F.; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; Tzen K.-Y.; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 73 | ||
| 2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | Chiu M.-J.; Chen Y.-F.; TA-FU CHEN ; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; Tzen K.-Y.; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 73 | ||
| 2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | MING-JANG CHIU ; Chen Y.-F.; Chen T.-F.; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; Tzen K.-Y.; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 73 | ||
| 2017 | Plasma α-synuclein predicts cognitive decline in Parkinson's disease | Lin C.-H.; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Journal of Neurology, Neurosurgery and Psychiatry | 51 | ||
| 2017 | Plasma α-synuclein predicts cognitive decline in Parkinson's disease | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; Chiu M.-J. | Journal of Neurology, Neurosurgery and Psychiatry | 51 | ||
| 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | Tang S.-C.; Yang K.-C.; Chen C.-H.; Yang S.-Y.; Chiu M.-J.; CHAU-CHUNG WU ; Jeng J.-S. | NeuroMolecular Medicine | 1 | 4 | |
| 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | Tang S.-C.; Yang K.-C.; Chen C.-H.; Yang S.-Y.; MING-JANG CHIU ; Wu C.-C.; Jeng J.-S. | NeuroMolecular Medicine | 4 | ||
| 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | SUNG-CHUN TANG ; Yang K.-C.; Chen C.-H.; Yang S.-Y.; Chiu M.-J.; Wu C.-C.; Jeng J.-S. | NeuroMolecular Medicine | 4 | ||
| 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | Tang S.-C.; Yang K.-C.; Chen C.-H.; Yang S.-Y.; Chiu M.-J.; Wu C.-C.; JIANN-SHING JENG | NeuroMolecular Medicine | 4 | ||
| 2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | Tang S.-C.; Yang K.-C.; CHIH-HAO CHEN ; Yang S.-Y.; Chiu M.-J.; Wu C.-C.; Jeng J.-S. | NeuroMolecular Medicine | 4 | ||
| 2011 | Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery | Lee J.-M.; Yang S.-Y.; Yang P.-W.; Shun C.-T.; Wu M.-T.; Hsu C.-H.; Lin C.-C.; Cheng J.-C.-H.; Wang Y.-H.; Chuang T.-H.; JIN-SHING CHEN ; Hsu H.-H.; Huang P.-M.; Kuo S.-W.; Lee Y.-C. | Annals of Surgical Oncology | 21 | 19 |
